NEW YORK, April 23, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of investors who purchased Colony NorthStar, Inc. ("Colony NorthStar") (NYSE:CLNS) securities between February 28, 2017 and March 1, 2018.
Click here to learn about the case: http://www.wongesq.com/pslra-c/colony-northstar-inc?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) Colony NorthStar’s Healthcare and Investment Management segments were performing worse than reported; (2) as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Colony NorthStar you have until June 5, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-c/colony-northstar-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]


Bathla Group Hires Administrators as Australia Housing Slump Deepens
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Trump Buys SpaceX Shares After Record IPO
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Nvidia Options Price in $280 Billion Earnings Swing
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Mercer International Stock Surges 45% on C$20 Million Canada Funding 



